Amedisys Inc Stock News

Amedisys (AMED) reports better-than-expected earnings for the third quarter on strong growth in the Home Health segment.

Amedisys, Inc's (AMED) CEO Paul Kusserow on Q3 2021 Results - Earnings Call Transcript

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BATON ROUGE, La., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for th

Last month, we discussed that Amedisys stock price could rebound over a one-month period after falling 3% in a week, based on its historical performance. However, AMED stock has seen a further decline

BATON ROUGE, La., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire r

EHC vs. AMED: Which Stock Is the Better Value Option?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

Investors can capitalize on Democratic spending no matter their affiliation. Here are the stocks to buy based on boosts in renewables, health care and infrastructure.

The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday's trading session. AMED stock has seen a gradual decline from levels of over $310 in Jan an

EHC vs. AMED: Which Stock Is the Better Value Option?

The prolonged and lingering impact of COVID-19 on Amedisys (AMED) Hospice business has hampered its ability to grow at the earlier-projected rates.

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q2 2021 Results - Earnings Call Transcript

The company provided disappointing full-year guidance.

BATON ROUGE, La., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2021.